SG11201807225VA - Novel prna three-way junctions - Google Patents

Novel prna three-way junctions

Info

Publication number
SG11201807225VA
SG11201807225VA SG11201807225VA SG11201807225VA SG11201807225VA SG 11201807225V A SG11201807225V A SG 11201807225VA SG 11201807225V A SG11201807225V A SG 11201807225VA SG 11201807225V A SG11201807225V A SG 11201807225VA SG 11201807225V A SG11201807225V A SG 11201807225VA
Authority
SG
Singapore
Prior art keywords
international
norman
prna
pct
english
Prior art date
Application number
SG11201807225VA
Other languages
English (en)
Inventor
Susan Schroeder
Alyssa Hill
Original Assignee
Univ Oklahoma
Alyssa Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oklahoma, Alyssa Hill filed Critical Univ Oklahoma
Publication of SG11201807225VA publication Critical patent/SG11201807225VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111General methods applicable to biologically active non-coding nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering N.A.
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/16Aptamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/351Conjugate
    • C12N2310/3519Fusion with another nucleic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/50Physical structure
    • C12N2310/52Physical structure branched
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00Applications; Uses
    • C12N2320/30Special therapeutic applications
    • C12N2320/32Special delivery means, e.g. tissue-specific

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SG11201807225VA 2016-02-26 2017-02-26 Novel prna three-way junctions SG11201807225VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662300517P 2016-02-26 2016-02-26
PCT/US2017/019556 WO2017147557A1 (en) 2016-02-26 2017-02-26 Novel prna three-way junctions

Publications (1)

Publication Number Publication Date
SG11201807225VA true SG11201807225VA (en) 2018-09-27

Family

ID=59685710

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201807225VA SG11201807225VA (en) 2016-02-26 2017-02-26 Novel prna three-way junctions

Country Status (10)

Country Link
US (1) US10900035B2 (ja)
EP (1) EP3419988A4 (ja)
JP (1) JP2019510511A (ja)
CN (1) CN109071591A (ja)
AU (1) AU2017222690A1 (ja)
BR (1) BR112018068247A2 (ja)
CA (1) CA3015667A1 (ja)
IL (1) IL261368A (ja)
SG (1) SG11201807225VA (ja)
WO (1) WO2017147557A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11976092B2 (en) 2018-02-09 2024-05-07 Ohio State Innovation Foundation RNA nanostructures, methods of making, and uses thereof
EP3759225A1 (en) * 2018-03-02 2021-01-06 Sixfold Bioscience Ltd. Compositions for delivery of cargo to cells
KR102656600B1 (ko) * 2018-07-12 2024-04-15 바이 야오 쥐 다 (베이징) 나노바이오 테크놀로지 컴퍼니 리미티드 핵산 나노입자, 이를 포함하는 약물 조성물, 독소루비신 함유 약물 및 그 제조 방법
EP4143316A2 (en) 2020-04-27 2023-03-08 Sixfold Bioscience Ltd. Compositions containing nucleic acid nanoparticles with modular functionality
WO2024069235A2 (en) 2022-09-30 2024-04-04 Sixfold Bioscience Ltd. Compositions containing oligonucleotides with theranostic applications

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8523301A (en) * 2000-08-23 2002-03-04 Purdue Research Foundation Prna chimera
US20050266416A1 (en) * 2002-09-18 2005-12-01 Purdue Research Foundation Molecular nanomotor
US9732337B2 (en) * 2009-06-16 2017-08-15 The United Stated of America, as represented by the Secretary, Department of Health & Human Services RNA nanoparticles and nanotubes
WO2012094586A2 (en) * 2011-01-07 2012-07-12 Peixuan Guo Synthetic non-covalently self-assembling bipartite prna chimeras
WO2012170372A2 (en) * 2011-06-08 2012-12-13 University Of Cincinnati Prna mutlivalent junction domain for use in stable multivalent rna nanoparticles
CN106795517A (zh) 2014-06-19 2017-05-31 肯塔基大学研究基金会 基于rna的组合物及用于预防性和治疗性疗法的佐剂

Also Published As

Publication number Publication date
EP3419988A1 (en) 2019-01-02
CA3015667A1 (en) 2017-08-31
BR112018068247A2 (pt) 2019-01-15
CN109071591A (zh) 2018-12-21
AU2017222690A1 (en) 2018-09-13
JP2019510511A (ja) 2019-04-18
IL261368A (en) 2018-10-31
US20190055551A1 (en) 2019-02-21
US10900035B2 (en) 2021-01-26
EP3419988A4 (en) 2019-11-27
WO2017147557A1 (en) 2017-08-31
WO2017147557A8 (en) 2018-10-04

Similar Documents

Publication Publication Date Title
SG11201807225VA (en) Novel prna three-way junctions
SG11201906395PA (en) Blockchain based data processing method and device
SG11201805300QA (en) Heterocyclic compounds as immunomodulators
SG11201806624XA (en) Deposition of molybdenum thin films using a molybdenum carbonyl precursor
SG11201811431VA (en) Multispecific antibodies against cd40 and cd137
SG11201805044WA (en) Compounds useful as kinase inhibitors
SG11201804787UA (en) Human immunodeficiency virus neutralizing antibodies
SG11201804901WA (en) Compounds for the treatment of cancer and inflammatory disease
SG11201803897QA (en) Pressure control device, dispenser comprising said pressure control device and method of manufacturing
SG11201809830WA (en) Selective reduction of cysteine-engineered antibodies
SG11201907364WA (en) Anti-tryptase antibodies, compositions thereof, and uses thereof
SG11201806267QA (en) Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose
SG11201804916PA (en) Three-dimensional polymer networks with channels situated therein
SG11201804890TA (en) Bipyrazolyl derivatives useful for the treatment of autoimmune diseases
SG11201500005SA (en) Pyrimidine pyrazolyl derivatives
SG11202000333UA (en) Bicyclic ketone compounds and methods of use thereof
SG11201805149XA (en) Compositions comprising 15-hepe and methods of using the same
SG11201804867RA (en) Coating compositions and treating method
SG11201806393QA (en) Use of gabaa receptor modulators for treatment of itch
SG11201809432UA (en) System, method and device for processing a transaction
SG11201804629XA (en) Compositions and methods for assessing the risk of cancer occurrence
SG11201408685WA (en) Antibacterial microelement chelates and the use thereof in animal feeds
SG11201908605XA (en) Antifouling article
SG11201906807VA (en) Compositions and methods for promoting hair growth with mpc1 inhibitors
SG11201803979PA (en) Sulfur-containing compounds as solvents